NCT02925143View on ClinicalTrials.gov

Improving Neuromuscular Monitoring and Reducing Residual Neuromuscular Blockade Via E-learning

NACompletedINTERVENTIONAL
Enrollment

6,525

Participants

Timeline

Start Date

November 21, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Neuromuscular Blockade
Interventions
OTHER

E-learning course in neuromuscular monitoring

An e-learning course designed to assess the challenges and common problems experienced by anesthetists when monitoring the neuromuscular blockade during general anesthesia.

Trial Locations (1)

Unknown

Herlev Hospital, Herlev

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Herlev Hospital

OTHER

NCT02925143 - Improving Neuromuscular Monitoring and Reducing Residual Neuromuscular Blockade Via E-learning | Biotech Hunter | Biotech Hunter